Travelling and hepatitis;Reisen und heptitis

Internist

Volumn 40, Issue 11, 1999, Pages 1137-1142

  Manns, M P ^a   Schuler A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; HEPATITIS VACCINE;

DELTA AGENT HEPATITIS; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS E; HUMAN; MORTALITY; PASSIVE IMMUNIZATION; PROPHYLAXIS; SHORT SURVEY; TRAVEL; VIRUS TRANSMISSION; ADULT; CHILD; DISEASE TRANSMISSION; FEMALE; PREGNANCY; REVIEW; RISK FACTOR; VIRUS HEPATITIS;

ADULT; CHILD; FEMALE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS D; HEPATITIS E; HEPATITIS, VIRAL, HUMAN; HUMANS; PREGNANCY; RISK FACTORS; TRAVEL; VIRAL HEPATITIS VACCINES;

EID: 0345534689     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050449     Document Type: Short Survey

References (28)

1. Branchenbild (1995) Gruner und Jahr Verlag, Hamburg
2. Steffen R (1991) In: Lobel HO, Steffen R, Kozarsky PE (eds) Travel Medicine 2, Proceedings of the Second Conference on International Travel Medicine. Atlanta, Georgia, USA
3. Frösner GG (1994) Epidemiologie der Hepatitis A+E. In: Maass G, Stück B (Hrsg) Virushepatitis A-E - Diagnose, Therapie, Prophylaxe. Kilian, pp 18-29
4. ANOMO-Studie (1996) 1988-1994. Schriftenreihe d. Bundesministeriums für Gesundheit. Nomos
5. Steffen R (1995) Hepatitis A in travelers: The European experience. J Infect Dis 171 [Suppl 1]:S24-28
6. Van Damme P, Thoelen S, Cramm M, De Groote K, Safary A, Meheus A (1994) Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence. J Med Virol 44(4):446-451
7. Clemens R, Safary A, Hepburn A, Roche C, Stanbury WJ, Andre FE (1995) Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis 171 [Suppl 1]:S44-49
8. Sobelavsy O (1980) Prevalence of markers of hepatitis B virus infection in various countries: a WHO collaborative study. Bull WHO 58:621-628
9. Jilg W (1996) Altersspezifische Inzidenz der Hepatitis B, 1991-94. Dtsch Ärztebl 47:3122-3126
10. Hawkes S, Hart GJ, Johnson AM, Shergold C, Ross E, Herbert KM, Mortimer P, Parry JV, Mabey D (1994) Risk behaviour and HIV prevalence in international travelers. AIDS 8:247-252
11. Stricker M, Steffen R, Hornung R et al. (1990) Flüchtige sexuelle Kontakte von Schweizer Touristen in den Tropen. Münch Med Wochenschr 132:175-177
12. Daniels DG, Kell P, Nelson MR, Barton SE (1992) Sexual behaviour amongst travellers: a study of genitourinary medicine clinic attenders. Int J STD AIDS 3(6):437-438
13. Steffen R (1991) Travel medicine - prevention based on epidemiological data. Trans R Soc Trop Med Hyg 85:156-162
14. West DJ. Clinical experience with hepatitis B vaccines. Am J Infect Control 17:172-180
15. Francis DP, Hadler SC, Thompson SE, Maynard JE, Ostrow DG, Altman N, Braff EH, O'Malley P, Hawkins D, Judson FN, Penley K, Nylund T, Christie G, Meyers F, Moore JN Jr, Gardner A, Doto IL, Miller JH, Reynolds GH, Murphy BL, Schable CA, Clark BT, Curran JW, Redeker AG (1982) The prevention of hepatitis B with vaccine. Report of the Centers for Disease Control multicenter efficacy trial among homosexual men. Ann Intern Med 97:362-366
16. André FE (1990) Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine 8 [Suppl]:74-78
17. Bock HL, Löscher T, Lorenz R et al. (1996) Beschleunigte Impfung gegen Hepatitis B - Wie schnell ist die aktive Immunisierung gegen Hepatitis B möglich? Der Kassenarzt 14:37-42
18. Wong DC, Purcell RH, Sreenivasan MA, Prasad SR, Pavri KM (1980) Epidemic and endemic hepatitis in India. Evidence for a non-A, non-B hepatitis virus aetiology. Lancet 2:876-879
19. Zhuang H (1992) Hepatitis E and strategies for its control. In:Viral hepatitis in China: Problems and control strategies. Monogr Virol 19:126-139
20. Centers for Disease Control and Prevention (1993) Hepatitis E among U.S.travelers, 1989-1992. MMWR 42:1-4
21. Coursaget P, Depril N, Yenen OS, Cavuslu S, Badur S (1993) Hepatitis E virus infection in Turkey. Lancet 342:810-811
22. Meng XJ, Halbur PG, Shapiro MS, Govindarajan S, Bruna JD, Mushawar IK, Purcell RH, Emerson SU (1998) Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol 72:9714-9721
23. Corwin A, Jarot K, Lubis I, Nasution K, Suparmawo S, Sumardiati A, Widodo S, Nazir S, Orndorff G, Choi Y, et al. ( 1995) Two years' investigation of epidemic hepatitis E virus transmission in West Kalimantan Borneo, Indonesia. Trans R Soc Trop Med Hyg 89:262-265
24. Khuroo MS, Dar MY (1992) Hepatitis E: evidence for person-to-person transmission and inability of low dose immune serum globulin from an Indian source to prevent it. Indian J Gastroenterol 11:113-116
25. Keefe EB (1995) Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 90:201-205
26. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, Ferraro T, Concia E (1998) Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 338:286-290
27. Manns MP, Schüler A (1998) Risk of hepatitis A superinfection in patients with underlying liver disease. Act Gastroentrol Belg 61:206-209
28. Keeffe E, Iwarson S, McMahon B, Lindsay K, Koff R, Manns M, Baumgarten R, Wiese M, Fourneau M, Safary A, Clemens R, Krause D (1998) Safety and immunogenicity of hepatitis. A vaccine in patients with chronic liver disease. Hepatology 27:881-886